Tacalyx is a biotech company that focuses on the discovery and development of novel anti-TACA (tumor-associated carbohydrate antigens) cancer therapies. The company develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.
Tacalyx total Funding
Tacalyx latest funding size
Time since last funding
|a year ago|
|Idinvest Partners, Boehringer Ingelheim Venture Fund, High-Tech Grunderfonds, coparion, Kurma Partners, Creathor Ventures|
When was Tacalyx founded?
Tacalyx was founded in 2019.
Who are Tacalyx competitors?
Competitors of Tacalyx include Quench Bio, AIVITA Biomedical and Veravas.
Where is Tacalyx headquarters?
Tacalyx headquarters is located at Müllerstraße 178, Berlin.
Where are Tacalyx offices?
Tacalyx has an office in Berlin.
How many offices does Tacalyx have?
Tacalyx has 1 office.
Receive alerts for 300+ data fields across thousands of companies